RB Goldberg, DM Kendall, MA Deeg, JB Buse, … - Diabetes care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We enrolled subjects with a diagnosis of type 2
diabetes (treated with diet alone or oral monotherapy) and dyslipidemia (not
treated with any lipid-lowering agents). After a 4-week placebo washout ... Cited by 334 - Related articles - BL Direct - All 13 versions
DM Kendall, CJ Rubin, P Mohideen, JM Ledeine … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—Analyses were conducted at week 24 for HbA 1c (A1C) and at week 12 for
lipid parameters. Mean A1C at baseline was 8.12 and 8.13% in muraglitazar and
pioglitazone groups, respectively. At week 24, muraglitazar reduced mean ... Cited by 74 - Related articles - BL Direct - All 8 versions
J Molnar, S Yu, N Mzhavia, C Pau, I … - Circulation research, 2005 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams &
Wilkins, a division of Wolters ... Diabetes Induces Endothelial ... Cited by 63 - Related articles - All 9 versions
RK Avramoglu, H Basciano, K Adeli - Clinica chimica acta, 2006 - Elsevier Insulin resistant states are commonly associated with an atherogenic
dyslipidemia that contributes to significantly higher risk of atherosclerosis
and cardiovascular disease. Indeed, disorders of carbohydrate and lipid ... Cited by 58 - Related articles - All 3 versions
HE Lebovitz - Diabetes, obesity & metabolism, 2006 - ccmjournal.org Evidence suggests that diabetes and cardiovascular disease (CVD) may share an
underlying cause(s), a theory known as the 'common soil' hypothesis. Insulin
resistance is central both to the progression from normal glucose tolerance ... Cited by 47 - Related articles - BL Direct - All 7 versions
IF Gazi, V Tsimihodimos, AD Tselepis, M Elisaf … - Expert Opin. Biol. Ther., 2007 - informahealthcare.com The National Cholesterol Education Programme Adult Treatment Panel III accepted
the predominance of small dense low-density lipoprotein (sdLDL) as an emerging
cardiovascular disease (CVD) risk factor. Most studies suggest that ... Cited by 43 - Related articles - BL Direct - All 4 versions
RJ Wood, JS Volek, Y Liu, NS Shachter, JH … - Journal of Nutrition, 2006 - Am Soc Nutrition To determine the effects of carbohydrate restriction (CR) with and without
soluble fiber on lipoprotein metabolism, 29 men participated in a 12-wk weight
loss intervention. Subjects were matched by age and BMI and randomly ... Cited by 36 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org MA Deeg, JB Buse, RB Goldberg, DM Kendall, … - Diabetes Care, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—This is a prospective, randomized, double-blind,
multicenter, parallel-group study. After a 4-week placebo washout period,
patients randomized to PIO (n = 369) were treated with 30 mg qd for 12 ... Cited by 35 - Related articles - BL Direct - All 5 versions
- ►sherbornegibbs.com [PDF] P Berhanu, MS Kipnes, MA Khan, AT Perez, … - Diabetes & Vascular Disease Research, 2006 - dvr.sagepub.com Abstract T he aim of this study was to evaluate changes in lipid profiles in
patients with type 2 diabetes after treat- ment conversion from rosiglitazone to
pioglitazone while maintaining stable statin and other lipid-altering ther- ... Cited by 35 - Related articles - BL Direct - All 9 versions
- ►jlr.org P Davidsson, J Hulthe, B Fagerberg, BM … - The Journal of Lipid Research, 2005 - ASBMB The exchangeable apolipoproteins present in small, dense LDL (sdLDL) and large,
buoyant LDL subclasses were evaluated with a quantitative proteomic approach in
patients with the metabolic syndrome and with type 2 diabetes, both with ... Cited by 34 - Related articles - BL Direct - All 4 versions
